• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国确诊精神分裂症的年度患病率:一种索赔数据分析方法。

Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.

作者信息

Wu Eric Q, Shi Lizheng, Birnbaum Howard, Hudson Teresa, Kessler Ronald

机构信息

Analysis Group, Inc., Boston, MA 02199, USA.

出版信息

Psychol Med. 2006 Nov;36(11):1535-40. doi: 10.1017/S0033291706008191. Epub 2006 Aug 15.

DOI:10.1017/S0033291706008191
PMID:16907994
Abstract

BACKGROUND

Schizophrenia is a debilitating chronic mental illness. However, the annual prevalence of schizophrenia is not well understood because of under-representation of schizophrenia patients in epidemiological surveys. This study used multiple administrative claims databases to estimate the annual prevalence of diagnosed schizophrenia in the USA.

METHOD

The annual prevalence of diagnosed schizophrenia in the USA was estimated for different health insurance coverage groups. The prevalence for privately insured individuals was calculated from an administrative claims database of approximately 3 million privately insured beneficiaries covering the period 1999-2003. The prevalence for Medicaid enrollees was calculated from California Medicaid claims covering the period 2000-2002. The prevalence for Medicare and Medicaid/Medicare dual eligibles was estimated using a combination of both databases. Published statistics were used to estimate the prevalence of schizophrenia in the uninsured and veteran populations and to weight the prevalence rates obtained to the population of the USA.

RESULTS

The 12-month prevalence of diagnosed schizophrenia in the USA in 2002 was estimated at 5.1 per 1000 lives. The Medicaid population was identified with the highest prevalence rate among the populations studied. Sensitivity analyses taking into consideration the Veterans Affairs population only changed the estimate slightly to 5.3 per 1000 lives.

CONCLUSION

Analyses of administrative claims data contribute to the understanding of the prevalence of diagnosed schizophrenia.

摘要

背景

精神分裂症是一种使人衰弱的慢性精神疾病。然而,由于精神分裂症患者在流行病学调查中的代表性不足,其年患病率尚未得到很好的了解。本研究使用多个行政索赔数据库来估计美国确诊精神分裂症的年患病率。

方法

针对不同医疗保险覆盖组估计美国确诊精神分裂症的年患病率。通过一个涵盖1999 - 2003年期间约300万私人保险受益人的行政索赔数据库计算私人保险个体的患病率。通过涵盖2000 - 2002年期间的加利福尼亚医疗补助索赔计算医疗补助参保者的患病率。医疗保险和医疗补助/医疗保险双重资格者的患病率使用两个数据库的组合进行估计。已发表的统计数据用于估计未参保人群和退伍军人人群中精神分裂症的患病率,并将获得的患病率加权至美国人口。

结果

2002年美国确诊精神分裂症的12个月患病率估计为每1000人中有5.1人。在所研究的人群中,医疗补助人群的患病率最高。仅考虑退伍军人事务人群的敏感性分析仅将估计值略微改变为每1000人中有5.3人。

结论

行政索赔数据分析有助于了解确诊精神分裂症的患病率。

相似文献

1
Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach.美国确诊精神分裂症的年度患病率:一种索赔数据分析方法。
Psychol Med. 2006 Nov;36(11):1535-40. doi: 10.1017/S0033291706008191. Epub 2006 Aug 15.
2
Twelve-month diagnosed prevalence of behavioral health disorders among elderly medicare and medicaid members.老年医疗保险和医疗补助成员中行为健康障碍的 12 个月确诊患病率。
Am J Geriatr Psychiatry. 2011 Nov;19(11):970-9. doi: 10.1097/JGP.0b013e3182011b66.
3
Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.充血性心力衰竭医疗补助受益人的药物治疗使用情况及依从性
Clin Ther. 2007 Aug;29(8):1771-83. doi: 10.1016/j.clinthera.2007.08.015.
4
Dually eligible individuals with AIDS: characteristics and health services use.患有艾滋病的双重资格个体:特征与医疗服务利用情况
J Health Soc Policy. 2001;14(1):19-35. doi: 10.1300/J045v14n01_02.
5
Administrative and claims records as sources of health care cost data.作为医疗保健成本数据来源的行政和理赔记录。
Med Care. 2009 Jul;47(7 Suppl 1):S51-5. doi: 10.1097/MLR.0b013e31819c95aa.
6
Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.抗精神病药物联合使用的患病率、使用模式及预测因素:1998 - 2003年多州医疗补助人群的经验
Clin Ther. 2007 Jan;29(1):183-95. doi: 10.1016/j.clinthera.2007.01.002.
7
Access to kidney transplantation among patients insured by the United States Department of Veterans Affairs.美国退伍军人事务部参保患者的肾移植情况。
J Am Soc Nephrol. 2007 Sep;18(9):2592-9. doi: 10.1681/ASN.2007010050. Epub 2007 Aug 8.
8
Health insurance status and hypertension monitoring and control in the United States.美国的医疗保险状况与高血压监测及控制
Am J Hypertens. 2007 Apr;20(4):348-53. doi: 10.1016/j.amjhyper.2006.11.007.
9
Uveitis in the elderly: epidemiological data from the National Long-term Care Survey Medicare Cohort.老年人葡萄膜炎:来自国家长期护理调查医疗保险队列的流行病学数据。
Ophthalmology. 2006 Feb;113(2):307.e1. doi: 10.1016/j.ophtha.2005.10.008. Epub 2006 Jan 10.
10
Epidemiologic study of smell disturbance in 2 medical insurance claims populations.两项医疗保险理赔人群嗅觉障碍的流行病学研究。
Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):748-57. doi: 10.1001/archotol.133.8.748.

引用本文的文献

1
Trends in schizophrenia-related mortality from 1999 to 2020: year, gender, and regional variations.1999年至2020年精神分裂症相关死亡率趋势:年份、性别和地区差异
Ann Med Surg (Lond). 2025 Jun 10;87(7):4336-4343. doi: 10.1097/MS9.0000000000003449. eCollection 2025 Jul.
2
Schizophrenia management: Systematic review of current medications and Phase-3 agents (2008-2024).精神分裂症的管理:对当前药物和三期药物(2008 - 2024年)的系统评价
Neurosci Appl. 2025 Feb 6;4:105507. doi: 10.1016/j.nsa.2025.105507. eCollection 2025.
3
Healthcare resource utilization burden associated with cognitive impairments identified through natural language processing among patients with schizophrenia in the United States.
在美国精神分裂症患者中,通过自然语言处理识别出的认知障碍所带来的医疗资源利用负担。
Schizophrenia (Heidelb). 2025 May 27;11(1):82. doi: 10.1038/s41537-025-00628-8.
4
Nursing strategies for implementing psychosocial interventions to address violence behavior in schizophrenia: a scoping review.实施心理社会干预以解决精神分裂症暴力行为的护理策略:一项范围综述
BMC Nurs. 2025 May 8;24(1):503. doi: 10.1186/s12912-025-03145-2.
5
Biomarker discovery using machine learning in the psychosis spectrum.在精神病谱系中使用机器学习进行生物标志物发现。
Biomark Neuropsychiatry. 2024 Dec;11. doi: 10.1016/j.bionps.2024.100107. Epub 2024 Aug 26.
6
Formative Evaluation of Post-Opera Live Discussion of the Center Cannot Hold Part 2 and Resilience Workshop.中心术后现场讨论第二部分及恢复力工作坊的形成性评估
Community Ment Health J. 2025 May;61(4):776-782. doi: 10.1007/s10597-024-01407-y. Epub 2024 Dec 3.
7
TV-46000, A Long-Acting Subcutaneous Antipsychotic Agent, Demonstrated Improved Patient-Centered Outcomes in Patients with Schizophrenia.长效皮下注射抗精神病药物TV-46000在精神分裂症患者中显示出以患者为中心的结局改善。
Neuropsychiatr Dis Treat. 2024 Oct 9;20:1901-1917. doi: 10.2147/NDT.S459104. eCollection 2024.
8
Characterizing Schizophrenia Spectrum Disorders: Results of the U.S. Mental and Substance Use Disorders Prevalence Study.精神分裂症谱系障碍的特征:美国精神和物质使用障碍患病率研究结果
Psychiatr Serv. 2025 Jan 1;76(1):2-12. doi: 10.1176/appi.ps.20240138. Epub 2024 Sep 23.
9
Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrollees.商业健康保险和医疗补助参保者中精神分裂症的患病率和发病率测量
Schizophrenia (Heidelb). 2024 Aug 22;10(1):68. doi: 10.1038/s41537-024-00490-0.
10
Global research in schizophrenia and serotonin: a bibliometric analysis.精神分裂症与血清素的全球研究:文献计量分析
Front Psychiatry. 2024 Aug 2;15:1436906. doi: 10.3389/fpsyt.2024.1436906. eCollection 2024.